Ernest D. Bush

Dr. Bush has spent over 28 years working in the field of biomedical R&D, most of which was spent working in preclinical safety departments for major pharmaceutical companies. From 1992 to 2005 he worked at Hoffmann-La Roche, Inc. and for the last five years of that time, led their Non-Clinical Drug Safety Department. In recent years, Dr. Bush has utilized his wide experience in the evaluation and assessment of new drug candidates to help small pharmaceutical companies, non-profit patient advocacy organizations and venture funding firms review their portfolios, rank or prioritize their opportunities, then plan and execute strategies to move them forward expeditiously and cost effectively. Dr. Bush holds a Ph.D. in Medicinal Chemistry from the University of Washington, an M.S. in Chemistry from the University of Oregon, and a B.A. in General Sciences from the University of Oregon.